Lederer & Associates Investment Counsel CA Acquires Shares of 4,129 CME Group Inc. (NASDAQ:CME)

Lederer & Associates Investment Counsel CA acquired a new stake in CME Group Inc. (NASDAQ:CMEFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 4,129 shares of the financial services provider’s stock, valued at approximately $959,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Meyer Handelman Co. acquired a new stake in shares of CME Group during the 4th quarter worth approximately $6,144,000. Worldquant Millennium Advisors LLC grew its position in shares of CME Group by 58.4% during the 3rd quarter. Worldquant Millennium Advisors LLC now owns 613,828 shares of the financial services provider’s stock worth $135,441,000 after buying an additional 226,306 shares during the period. Geode Capital Management LLC grew its position in shares of CME Group by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after buying an additional 142,692 shares during the period. Bank of Montreal Can grew its position in shares of CME Group by 41.8% during the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock worth $224,432,000 after buying an additional 303,169 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its position in shares of CME Group by 18.3% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,826,501 shares of the financial services provider’s stock worth $403,017,000 after buying an additional 283,171 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Morgan Stanley lifted their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Oppenheimer lifted their price objective on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Citigroup lowered shares of CME Group from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $229.27.

Read Our Latest Stock Report on CME

CME Group Stock Performance

Shares of CME stock opened at $236.52 on Monday. The company’s fifty day simple moving average is $234.73 and its 200-day simple moving average is $222.63. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a market cap of $85.23 billion, a PE ratio of 24.87, a P/E/G ratio of 5.37 and a beta of 0.57. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02.

CME Group Increases Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were given a $5.80 dividend. The ex-dividend date was Friday, December 27th. This is a positive change from CME Group’s previous dividend of $2.50. CME Group’s payout ratio is currently 48.37%.

CME Group declared that its Board of Directors has authorized a share buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.